Aethlon Medical (AEMD)

• Market cap: $8.8M
• 1 day: -0.74%
• 5 days: -21.12%
• 1 month: 82.27%
• 3 months: 59.33%
• 6 months: 49.01%
• Year to date: -21.21%
• 1 year: -67.51%
• 5 years: -96.27%
• 10 years: -99.95%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Employees: 14

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

110% more capital invested

Capital invested by funds: $89.2K [Q2] → $188K (+$98.3K) [Q3]

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

0.96% more ownership

Funds ownership: 1.97% [Q2] → 2.92% (+0.96%) [Q3]

0% more funds holding

Funds holding: 18 [Q2] → 18 (+0) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $7 1,011% upside
• Avg. target: $7 1,011% upside
• High target: $7 1,011% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Vernon Bernardino 41% 1-year accuracy 24 / 59 met price target

1,011% upside $7

Buy Reiterated

15 Nov 2024